News

Nova Mentis Biotech Corp Signs Psilocybin Research Agreement with France-Based Physiogenex

Vancouver, British Columbia – August 31, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Nova Mentis Biotech Corp. (“NMBC”) has signed a Master Service Agreement with leading preclinical Contract Research Organization for metabolic disorders, Physiogenex. “I am delighted to
Read More »

Nova Mentis Re-Appoints Robert W.E. Laurie as Advisory Board Chair and Psychedelics Regulatory Advisor

  Vancouver, British Columbia – July 08, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFD) (“NOVA” or the “Company”) is pleased to announce  Mr. Robert W.E. Laurie has been re-appointed Advisory Board Chair and additionally appointed  Psychedelics Regulatory Advisor. Robert W.E. Laurie is an international lawyer, qualified in England and called
Read More »

Nova Mentis Appoints Dr. Aylia Mohammadi to Board of Directors

  Vancouver, British Columbia – July 02, 2020 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFD) (“NOVA” or the “Company”) is pleased to announce that Dr. Aylia Mohammadi has joined the Company’s Board of Directors. Dr. Aylia Mohammadi (BSc, MSc, PhD) is an experienced scientist with research expertise in both basic science
Read More »

Liberty Leaf Announces Effective Date of Consolidation, Name and Symbol Change

  Vancouver, British Columbia – June 24, 2020 – Liberty Leaf Holdings Ltd. (CSE: LIB) (FSE: HN3P) (OTCPK: LIBFF) (“LIB” or the “Company”) is pleased to confirm the effective date for the consolidation of one (1) post-consolidation share for every four (4) pre-consolidation shares and concurrent name and symbol change, as announced on June 22, 2020.
Read More »

Liberty Leaf to Acquire Nova Mentis Biotech Corp.

  Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market   Vancouver, British Columbia – June 22, 2020 – Liberty Leaf Holdings Ltd. (CSE: LIB) (FSE: HN3P) (OTCPK: LIBFF) (“LIB” or the “Company”) is pleased to announce that it has entered into an agreement (the “Agreement”) with Nova Mentis Biotech Corp. (“NOVA”), pursuant
Read More »